69 related articles for article (PubMed ID: 31452441)
1. ETS Factor ETV5 Activates the Mutant Telomerase Reverse Transcriptase Promoter in Thyroid Cancer.
Bullock M; Lim G; Zhu Y; Åberg H; Kurdyukov S; Clifton-Bligh R
Thyroid; 2019 Nov; 29(11):1623-1633. PubMed ID: 31452441
[No Abstract] [Full Text] [Related]
2. Characterization of Allele-Specific Regulation of Telomerase Reverse Transcriptase in Promoter Mutant Thyroid Cancer Cell Lines.
McKelvey BA; Gilpatrick T; Wang Y; Timp W; Umbricht CB; Zeiger MA
Thyroid; 2020 Oct; 30(10):1470-1481. PubMed ID: 32228178
[No Abstract] [Full Text] [Related]
3. Characterization of human telomerase reverse transcriptase promoter methylation and transcription factor binding in differentiated thyroid cancer cell lines.
Avin BA; Wang Y; Gilpatrick T; Workman RE; Lee I; Timp W; Umbricht CB; Zeiger MA
Genes Chromosomes Cancer; 2019 Aug; 58(8):530-540. PubMed ID: 30664813
[TBL] [Abstract][Full Text] [Related]
4. Spectrum of TERT promoter mutations and mechanisms of activation in thyroid cancer.
Panebianco F; Nikitski AV; Nikiforova MN; Nikiforov YE
Cancer Med; 2019 Oct; 8(13):5831-5839. PubMed ID: 31408918
[TBL] [Abstract][Full Text] [Related]
5. Interplay between TERT promoter mutations and methylation culminates in chromatin accessibility and TERT expression.
Salgado C; Roelse C; Nell R; Gruis N; van Doorn R; van der Velden P
PLoS One; 2020; 15(4):e0231418. PubMed ID: 32267900
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal and MAPK Expression Signatures Associate with Telomerase Promoter Mutations in Multiple Cancers.
Stern JL; Hibshman G; Hu K; Ferrara SE; Costello JC; Kim W; Tamayo P; Cech TR; Huang FW
Mol Cancer Res; 2020 Jul; 18(7):1050-1062. PubMed ID: 32276990
[TBL] [Abstract][Full Text] [Related]
7.
Rusinek D; Pfeifer A; Cieslicka M; Kowalska M; Pawlaczek A; Krajewska J; Szpak-Ulczok S; Tyszkiewicz T; Halczok M; Czarniecka A; Zembala-Nozynska E; Chekan M; Lamch R; Handkiewicz-Junak D; Ledwon A; Paliczka-Cieslik E; Kropinska A; Jarzab B; Oczko-Wojciechowska M
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32560331
[TBL] [Abstract][Full Text] [Related]
8. Highly recurrent TERT promoter mutations in human melanoma.
Huang FW; Hodis E; Xu MJ; Kryukov GV; Chin L; Garraway LA
Science; 2013 Feb; 339(6122):957-9. PubMed ID: 23348506
[TBL] [Abstract][Full Text] [Related]
9. Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer.
Bell RJ; Rube HT; Kreig A; Mancini A; Fouse SD; Nagarajan RP; Choi S; Hong C; He D; Pekmezci M; Wiencke JK; Wrensch MR; Chang SM; Walsh KM; Myong S; Song JS; Costello JF
Science; 2015 May; 348(6238):1036-9. PubMed ID: 25977370
[TBL] [Abstract][Full Text] [Related]
10. Telomerase Upregulation Induces Progression of Mouse BrafV600E-Driven Thyroid Cancers and Triggers Nontelomeric Effects.
Landa I; Thornton CEM; Xu B; Haase J; Krishnamoorthy GP; Hao J; Knauf JA; Herbert ZT; Martínez P; Blasco MA; Ghossein R; Fagin JA
Mol Cancer Res; 2023 Nov; 21(11):1163-1175. PubMed ID: 37478162
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and Prognostic Values of Telomerase Reverse Transcriptase (
Yoo H; Kim HS
Cancer Genomics Proteomics; 2023; 20(6):626-636. PubMed ID: 37889060
[TBL] [Abstract][Full Text] [Related]
12. TERT promoter alterations could provide a solution for Peto's paradox in rodents.
Vedelek B; Maddali AK; Davenova N; Vedelek V; Boros IM
Sci Rep; 2020 Nov; 10(1):20815. PubMed ID: 33257697
[TBL] [Abstract][Full Text] [Related]
13. Predicting the prognosis of glioma patients with TERT promoter mutations and guiding the specific immune profile of immune checkpoint blockade therapy.
Cao W; Lan J; Hu C; Kong J; Xiang L; Zhang Z; Sun Y; Zeng Z; Lei S
Aging (Albany NY); 2024 Mar; 16(6):5618-5633. PubMed ID: 38499392
[TBL] [Abstract][Full Text] [Related]
14. FOXR2 Is an Epigenetically Regulated Pan-Cancer Oncogene That Activates ETS Transcriptional Circuits.
Tsai JW; Cejas P; Wang DK; Patel S; Wu DW; Arounleut P; Wei X; Zhou N; Syamala S; Dubois FPB; Crane A; Pelton K; Vogelzang J; Sousa C; Baguette A; Chen X; Condurat AL; Dixon-Clarke SE; Zhou KN; Lu SD; Gonzalez EM; Chacon MS; Digiacomo JJ; Kumbhani R; Novikov D; Hunter J; Tsoli M; Ziegler DS; Dirksen U; Jager N; Balasubramanian GP; Kramm CM; Nathrath M; Bielack S; Baker SJ; Zhang J; McFarland JM; Getz G; Aguet F; Jabado N; Witt O; Pfister SM; Ligon KL; Hovestadt V; Kleinman CL; Long H; Jones DTW; Bandopadhayay P; Phoenix TN
Cancer Res; 2022 Sep; 82(17):2980-3001. PubMed ID: 35802025
[TBL] [Abstract][Full Text] [Related]
15. Genetic Determinants for Prediction of Outcome of Patients with Papillary Thyroid Carcinoma.
Póvoa AA; Teixeira E; Bella-Cueto MR; Batista R; Pestana A; Melo M; Alves T; Pinto M; Sobrinho-Simões M; Maciel J; Soares P
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33922635
[TBL] [Abstract][Full Text] [Related]
16. Pooled genetic screens to identify vulnerabilities in TERT-promoter-mutant glioblastoma.
Tu KJ; Stewart CE; Hendrickson PG; Regal JA; Kim SY; Ashley DM; Waitkus MS; Reitman ZJ
Oncogene; 2023 Oct; 42(44):3274-3286. PubMed ID: 37741952
[TBL] [Abstract][Full Text] [Related]
17. TERTmonitor-qPCR Detection of
Brás JP; Jesus TT; Prazeres H; Lima J; Soares P; Vinagre J
Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761833
[TBL] [Abstract][Full Text] [Related]
18. E4F1 and ZNF148 are transcriptional activators of the -57A > C and wild-type
Chua BH; Zaal Anuar N; Ferry L; Domrane C; Wittek A; Mukundan VT; Jha S; Butter F; Tenen DG; Defossez PA; Kappei D
Genome Res; 2023 Nov; 33(11):1893-905. PubMed ID: 37918959
[TBL] [Abstract][Full Text] [Related]
19. Adipocyte signaling affects thyroid-specific gene expression via down-regulation of TTF-2/FOXE1.
Zamboni M; Strimpakos G; Poggiogalle E; Donini LM; Civitareale D
J Mol Endocrinol; 2023 Jan; 70(1):. PubMed ID: 36347053
[TBL] [Abstract][Full Text] [Related]
20. Risk stratification by combining common genetic mutations and TERT promoter methylation in papillary thyroid cancer.
Sang Y; Hu G; Xue J; Chen M; Hong S; Liu R
Endocrine; 2024 Feb; ():. PubMed ID: 38356100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]